Top compounds associated with response to TCF24


Feature Type Standardized
Nominal ANOVA
mRNA Irinotecan gCSI pan-cancer AAC -0.058 0.3
mRNA Nilotinib CTRPv2 pan-cancer AAC 0.039 0.3
mRNA nintedanib CTRPv2 pan-cancer AAC -0.04 0.3
mRNA BMS-345541 CTRPv2 pan-cancer AAC 0.039 0.3
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.3
mRNA OSI-930 CTRPv2 pan-cancer AAC 0.038 0.3
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.039 0.3
mRNA AEW541 CCLE pan-cancer AAC 0.048 0.3
mRNA Platin CTRPv2 pan-cancer AAC -0.039 0.3
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.04 0.3
Download CSV